Clarion Wealth Managment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Buy
7,816
+18
+0.2% +$4.2K 1.6% 12
2026
Q1
$1.91M Buy
7,798
+17
+0.2% +$3.96K 1.73% 11
2025
Q4
$1.61M Buy
7,781
+13
+0.2% +$2.57K 1.49% 16
2025
Q3
$1.44M Sell
7,768
-64
-0.8% -$11K 1.42% 17
2025
Q2
$1.2M Buy
+7,832
New +$1.2M 1.31% 20

Other funds holding JNJ

Clarion Wealth Managment Partners's JNJ Position: Q2 2026 in Review

Clarion Wealth Managment Partners increased its Johnson & Johnson (JNJ) stake by 0.23% in Q2 2026, buying an estimated $4.2K and bringing the position to 7,816 shares worth $1.98M. The position accounts for 1.6% of the portfolio, ranked #12.

Clarion Wealth Managment Partners first reported a position in JNJ in Q2 2025 and has held it in 5 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Clarion Wealth Managment Partners held 7,816 shares of Johnson & Johnson worth $1.98M as of Q2 2026.
  • Clarion Wealth Managment Partners bought 18 Johnson & Johnson shares in Q2 2026, an estimated $4.2K.
  • Johnson & Johnson made up 1.6% of Clarion Wealth Managment Partners's portfolio in Q2 2026, its #12 holding.
  • Clarion Wealth Managment Partners first reported a position in Johnson & Johnson in Q2 2025 and has held it in 5 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Clarion Wealth Managment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.